Godavari Bioref.

Who are the top shareholders of the Godavari Bioref.?

The top shareholders of Godavari Bioref. include Somaiya Agencies Private Limited with 17.3%, mutual funds holding 10.95% (led by HDFC Mutual Fund at 4.1%), and individual investors at 17.64%. There are also eight foreign institutional investors with a combined 0.97%, and no pledged promoter holdings are reported.

The top shareholders of Godavari Bioref. include a mix of promoters, mutual funds, and individual investors. The majority shareholder is Somaiya Agencies Private Limited, which holds 17.3% of the company. Additionally, mutual funds collectively hold 10.95% across six schemes, with HDFC Mutual Fund - HDFC Manufacturing Fund being the highest public shareholder at 4.1%. Individual investors account for 17.64% of the holdings. There are also eight foreign institutional investors (FIIs) holding a small portion of 0.97%. Notably, there are no pledged promoter holdings reported.

Has Godavari Bioref. declared dividend?

No Dividend History Available

Who are the peers of the Godavari Bioref.?

Godavari Bioref.'s peers include Hind. Unilever, ITC, Nestle India, and others, with varying management and growth ratings. It has an average management risk and below-average capital structure, with its 1-year return not applicable.

Peers: The peers of Godavari Bioref. are Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, Lotus Chocolate, Vadilal Enterp., Mukka Proteins, Jindal Photo, and KSE.<BR><BR>Quality Snapshot: Excellent management risk is observed at ITC, Nestle India, and Britannia Inds., while Good management risk is found at Hind. Unilever and Godrej Consumer. Average management risk is present at Godavari Bioref., Lotus Chocolate, Vadilal Enterp., Mukka Proteins, Jindal Photo, and KSE. Growth ratings show Excellent growth at Lotus Chocolate, Good growth at Vadilal Enterp. and Mukka Proteins, while Below Average growth is noted at Hind. Unilever, ITC, Nestle India, Britannia Inds., Godrej Consumer, and Godavari Bioref. Capital Structure is rated Excellent for Hind. Unilever, ITC, Nestle India, Britannia Inds., and Godrej Consumer, while Below Average is noted for Godavari Bioref., Lotus Chocolate, Mukka Proteins, Jindal Photo, and KSE.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Vadilal Enterp. at 215.15%, while the lowest is Godavari Bioref. with an N/A return. Godavari Bioref.'s 1-year return is not applicable, indicating it has not been reported. Additionally, peers with negative six-month returns include Lotus Chocolate, Mukka Proteins, and Godavari Bioref.

Is Godavari Bioref. overvalued or undervalued?

As of May 26, 2025, Godavari Bioref. is considered overvalued with a valuation grade of "attractive," reflected in its negative PE ratio of -53.80, high EV to EBITDA of 20.92, and low ROCE of 4.46%, especially when compared to peers like E.I.D.-Parry and Balrampur Chini Mills.

As of 26 May 2025, the valuation grade for Godavari Bioref. has moved from very attractive to attractive. The company appears to be overvalued based on its current financial metrics. Key ratios include a PE ratio of -53.80, an EV to EBITDA of 20.92, and a ROCE of 4.46%. In comparison, E.I.D.-Parry (India) Ltd. has a PE ratio of 27.55 and an EV to EBITDA of 5.63, while Balrampur Chini Mills Ltd. shows a PE of 28.14 and an EV to EBITDA of 21.19, indicating that Godavari Bioref. is trading at a significant premium relative to its peers.<BR><BR>The company's financials reflect challenges, particularly with a negative ROE of -5.49% and a PEG ratio of 0.00, suggesting limited growth prospects. While the stock has performed well recently, with a 1-month return of 74.99% compared to the Sensex's 3.80%, this may not be sustainable given the underlying valuation metrics. Overall, the analysis indicates that Godavari Bioref. is overvalued in the current market context.

What does Godavari Bioref. do?

Godavari Biorefineries Ltd is a small-cap FMCG company that specializes in biorefinery operations. As of March 2025, it reported net sales of ₹5,795 Cr and a net profit of ₹719 Cr.

Overview:<BR>Godavari Biorefineries Ltd operates in the FMCG industry and is categorized as a small-cap company.<BR><BR>History:<BR>The company was originally incorporated as 'Godavari Investment and Finance Corporation Limited' in 1956. It changed its name to 'Godavari Biorefineries Limited' in 2006. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>Net Sales: 5,795 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 719 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,543 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: N/A <BR>Industry P/E: 25 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.28 <BR>Return on Equity: -5.49% <BR>Price to Book: 3.00<BR><BR>Contact Details:<BR>No Company Details Available <BR>Registrar Address: Not available.

How big is Godavari Bioref.?

As of 24th July, Godavari Biorefineries Ltd has a market capitalization of 1,801.00 Cr, with recent net sales of 1,870.25 Cr and a net loss of 23.42 Cr over the last four quarters.

As of 24th July, <BR><BR>Market Cap: Godavari Biorefineries Ltd has a market capitalization of 1,801.00 Cr and is classified as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest four quarters is 1,870.25 Cr, while the sum of Net Profit for the same period shows a loss of 23.42 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2024. Shareholder's Funds are valued at 500.68 Cr, and Total Assets amount to 1,991.66 Cr.

How has been the historical performance of Godavari Bioref.?

Godavari Bioref. has faced significant fluctuations in financial performance, with net sales decreasing from 2,014.69 crore in March 2023 to 1,870.25 crore in March 2025, and profitability declining sharply, resulting in a profit after tax of -23.41 crore in March 2025. The company has struggled with rising expenditures and a notable drop in cash flow from operations.

Answer:<BR>The historical performance of Godavari Bioref. has shown significant fluctuations over the years, particularly in its net sales and profitability.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Godavari Bioref. reported net sales of 1,870.25 crore, an increase from 1,686.67 crore in March 2024 but a decrease from 2,014.69 crore in March 2023. The total operating income mirrored this trend, reaching 1,870.25 crore in March 2025. The company's total expenditure, excluding depreciation, rose to 1,766.60 crore in March 2025 from 1,553.13 crore in March 2024, leading to an operating profit (PBDIT) of 120.31 crore, down from 147.94 crore the previous year. This decline in profitability is reflected in the profit before tax, which fell to -1.54 crore in March 2025 from 12.45 crore in March 2024, resulting in a profit after tax of -23.41 crore compared to 12.30 crore in the prior year. The company's total assets decreased slightly to 1,955.09 crore in March 2025 from 1,991.50 crore in March 2024, while total liabilities also saw a decline to 1,955.09 crore from 1,991.50 crore. Cash flow from operating activities dropped significantly to 6.00 crore in March 2025 from 185.00 crore in March 2024, indicating challenges in generating cash from core operations. Overall, Godavari Bioref. has experienced a challenging financial environment, marked by declining profits and fluctuating sales.

Is Godavari Bioref. technically bullish or bearish?

As of December 1, 2025, the market trend has shifted to sideways with neutral indicators, as the weekly MACD and Bollinger Bands are bearish, while daily moving averages are mildly bullish but lack strong momentum.

As of 1 December 2025, the technical trend has changed from mildly bullish to sideways. The current stance is neutral, with weak indicators supporting this position. The weekly MACD is bearish, and Bollinger Bands also indicate a bearish trend. The daily moving averages are mildly bullish, but this is offset by the lack of signals from the RSI and the KST being mildly bearish. Additionally, Dow Theory shows no trend in both weekly and monthly time frames. Overall, the indicators suggest a lack of strong momentum in either direction.

When is the next results date for Godavari Biorefineries Ltd?

The next results date for Godavari Biorefineries Ltd is 22 May 2026.

The next results date for Godavari Biorefineries Ltd is scheduled for 22 May 2026.

Are Godavari Biorefineries Ltd latest results good or bad?

Godavari Biorefineries Ltd's latest results show a strong quarter-on-quarter recovery with a net profit increase of 540.97% and a revenue rise of 22.67%. However, year-on-year comparisons reveal a 26.48% drop in net profit and a 2.66% decline in revenue, indicating concerns about long-term growth sustainability.

The latest results for Godavari Biorefineries Ltd show a mixed picture. On one hand, the company reported a significant recovery in Q4 FY26, with a net profit of ₹52.88 crore, marking an impressive 540.97% increase quarter-on-quarter. Revenue also rose by 22.67% to ₹564.10 crore compared to the previous quarter. Additionally, operating margins improved to 15.28%, reflecting better pricing power and operational efficiency.<BR><BR>However, when looking at year-on-year performance, the results are less favorable. The net profit decreased by 26.48% from ₹71.93 crore in Q4 FY25, and revenue fell by 2.66% from ₹579.50 crore in the same quarter last year. This highlights a struggle to maintain consistent growth across fiscal years.<BR><BR>Overall, while the sequential recovery is a positive sign, the year-on-year declines raise concerns about the sustainability of this performance. Investors should be cautious, as the company's financial history has shown significant volatility, swinging from losses to profits, which complicates the outlook for future earnings stability.

Why is Godavari Biorefineries Ltd falling/rising?

As of 25-May, Godavari Biorefineries Ltd's stock price is at Rs 293.00, down 7.64%, with a significant decline of 10.38% over the last three days. The stock has underperformed compared to the sector and is currently below several moving averages, indicating a short-term downward trend.

As of 25-May, Godavari Biorefineries Ltd's stock price is falling, currently at Rs 293.00, which reflects a decrease of Rs 24.25 or 7.64%. The stock has underperformed significantly compared to the sector, with a performance today that is down by 7.95%. Over the last three days, the stock has experienced a consecutive decline, totaling a drop of 10.38% in returns during this period. <BR><BR>In terms of broader performance, the stock has seen a decline of 4.01% over the past week and 12.05% over the past month, while the benchmark Sensex has shown positive returns during these periods. Additionally, the stock's trading activity indicates a decrease in investor participation, with delivery volume on 22 May falling by 12.37% compared to the five-day average. The stock also touched an intraday low of Rs 291, indicating a significant drop of 8.27% at that point. <BR><BR>While the stock remains above its 100-day and 200-day moving averages, it is currently below its 5-day, 20-day, and 50-day moving averages, suggesting a short-term downward trend. Overall, these factors contribute to the observed decline in the stock price of Godavari Biorefineries Ltd.

Which are the latest news on Godavari Bioref.?

Should I buy, sell or hold Godavari Biorefineries Ltd?